RD3 antibody (N-Term)
-
- Target See all RD3 Antibodies
- RD3 (Retinal Degeneration 3 (RD3))
-
Binding Specificity
- N-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This RD3 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- RD3 antibody was raised against the N terminal of RD3
- Purification
- Affinity purified
- Immunogen
- RD3 antibody was raised using the N terminal of RD3 corresponding to a region with amino acids GQMREAERQQRERSNAVRKVCTGVDYSWLASTPRSTYDLSPIERLQLEDV
- Top Product
- Discover our top product RD3 Primary Antibody
-
-
- Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
RD3 Blocking Peptide, catalog no. 33R-3503, is also available for use as a blocking control in assays to test for specificity of this RD3 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RD3 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- RD3 (Retinal Degeneration 3 (RD3))
- Alternative Name
- RD3 (RD3 Products)
- Synonyms
- C1orf36 antibody, LCA12 antibody, 3322402L07Rik antibody, rd-3 antibody, rd3 antibody, retinal degeneration 3 antibody, RD3 antibody, Rd3 antibody
- Background
- RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
- Molecular Weight
- 23 kDa (MW of target protein)
-